Case of steroid-sensitive nephrotic syndrome in a child with orphan disease – leucinosis.

BACKGROUND.  The article presents the case of a clinical and laboratory complex of a recurrent hormone-sensitive variant of nephrotic syndrome in a patient with leucinosis (maple syrup disease). THE AIM: to study the clinical laboratory features of nephrotic syndrome in a child with orphan disease – leucinosis. A PATIENT. A 4-year-old child born in a consanguineous marriage, who had previously been diagnosed with a rare genetic disease leucinosis, was examined. The manifestation of leucinosis began from the 8th day of birth. Based on the results of a molecular genetic study the diagnosis was pinpointed as leucinosis with an autosomal recessive mode of inheritance, classic neonatal (maple syrup disease). At the age of 4 the child developed a clinical and laboratory complex of nephrotic syndrome. RESULTS.  The onset of nephrotic syndrome was characterized by a hormone-sensitive course. After completion of the course of glucocorticosteroid therapy, there was a relapse because of acute respiratory infection which also turned out to be hormone-sensitive. Kidney function was not impaired. There were no crises of leucinosis due to nephrotic syndrome. CONCLUSION. Taking into account the development of nephrotic syndrome in a child with a genetically determined disease, a molecular genetic examination should be done to exclude the hereditary nature of the developed nephrotic syndrome. The examination is of great clinical importance for determining treatment tactics, cytostatic therapy, doing a kidney biopsy in order to determine the morphological form of glomerulonephritis, prognosis of progression to the end-stage renal failure.

1. https://www.orpha.net (дата обращения 27.02.2021)

2. Menkes JH, Hurst PL, Craig JM. A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics1954 Nov;14(5):462–467. PMID: 13214961

3. Nikolaeva EA, Denisova SN, Kurbatov MB et. al. Maple syrup disease. Voprosy detskoj dietologii 2004;2(6):76–79 (In Russ.)

4. Krasnopol'skaya KD. Hereditary metabolic diseases. А reference book for doctors. ROO «Centr social'noj adaptacii i reabilitacii Fohat», M., 2005; 168–172 (In Russ.)

5. Bushueva TV, Borovik TE, Nikitina NV et al. Leucinosis (urine maple syrup disease). Voprosy detskoj dietologii 2010;8(1):60–65 (In Russ.)

6. Baranov AA, Borovik TE, Bushueva TV et al. Maple syrup disease in children. Clinical guidelines. M., 2018;35 (In Russ.)

7. Morton DH. Diagnosis and treatment of MSUD: a study of 36 patients. Pediatrics 2002;109:999–1008. doi: 10.1542/peds.109.6.999

8. Sitta A, Ribas GS, Mescka CP, Barschak AG, Wajner M, Vargas CR. Neurological damage in MSUD: the role of oxidative stress. Cell Mol Neurobiol2014 Mar;34(2):157–165. doi: 10.1007/s10571-013-0002-0

9. Fariello G, Orazi C, Malena S et al. US patterns in maple syrup urine disease. Riv Neuroradiol1994; 7: 263–264

10. https://www.omim.org(дата обращения 27.02.2021)

11. Hereditary kidney disease in children. A guide for doctors. Red: ND Savenkova. Levsha. Sankt-Peterburg, SPb, 2020;400 (In Russ.)

12. Savenkova ND. Hereditary nephrotic syndrome in pediatric and adult patients. Nefrologiya2020; 24(3):15–27 (In Russ). doi:10.36485/1561-6274-2020-24-3-15-27

13. Jalanko H, Holmberg C. Congenital Nephrotic Syndrome. Pediatric Nephrology. Eds: ED Avner, WE Harmon, P Niaudet, N Yoshikawa, F Emma, SL Goldstein. Springer, 2016;1:753–769. doi: 10.1007/s00467-007-0633-9

14. Boyer О, Tory K, Machuca E, Antignac С. Idiopathic Nephrotic Syndrome in Children: Genetic Aspects. Pediatric Nephrology.Eds: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL. Springer, 2016;1:805–837. doi: 10.1007/978-3-662-43596-0_23

15. Savenkova ND. Treatment strategy for initial of relapsing and frequent relapsing steroid sensitive and steroid dependent minimal change nephritic syndrome in children. Nephrology 2013; 17(3):17–25 (In Russ.). doi: 10.24884/1561-6274-2013-17-3-17-25

16. Preston R, Stuart HM, Lennon R. Genetic testing in steroidresistant nephrotic syndrome: why, who, when and how? Pediatr Nephrol 2019;34(2):195–210. doi: 10.1007/s00467-017-3838-6